Pill not linked to breast cancer

Oral contraceptive use is not associated with a significantly increased risk of breast cancer.

Written byTudor Toma
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The oral contraceptive pill revolutionized the reproductive choices for women, but there has remained a suggestion that its use could increase the risk of developing breast cancer. In 27 June New England Journal of Medicine, Polly Marchbanks and colleagues at Centers for Disease Control and Prevention, Atlanta, show that current or former oral-contraceptive use is not associated with a significantly increased risk of breast cancer (N Engl J Med 2002, 346:2025-2032).

Marchbanks et al. conducted a population-based, case–control study on 4575 women with breast cancer and 4682 controls. They observed that the use of oral contraceptives by women with a family history of breast cancer was not associated with an increased risk of developing breast cancer, nor was beginning to take the pill at a young age. The relative risk of breast cancer was 1.0 for women who were currently using oral contraceptives and 0.9 for those who had previously ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems